• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/13 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Patent holdings for IPC class C07D 295/13

Total number of patents in this class: 571

10-year publication summary

42
33
38
32
32
45
44
40
67
31
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Acuitas Therapeutics Inc.
137
22
Massachusetts Institute of Technology
10251
13
The Trustees of the University of Pennsylvania
4415
12
The Regents of the University of California
20745
11
Beam Therapeutics Inc.
289
10
Dow Global Technologies LLC
10944
8
Modernatx, Inc.
1291
7
South China University of Technology
1904
7
Recurium IP Holdings, LLC
125
7
Centre National de La Recherche Scientifique
11023
6
The Salk Institute for Biological Studies
450
6
Albert Einstein College of Medicine, Inc.
596
5
Pharmatrophix, Inc.
25
5
PTC Therapeutics, Inc.
475
5
University College Cardiff Consultants Limited
254
5
The Procter & Gamble Company
21855
4
BASF SE
21303
4
Allergan, Inc.
2167
4
Abbvie Inc.
1836
4
The Board of Trustees of the University of Illinois
2751
4
Other owners 422